BEIJING, Dec. 4 (Xinhua) -- National Health and Family Planning Commission (NHFPC) began to solicit public opinions on 13th Five-Year Plan (2016-2020) for "Health China" on Friday.
According to NHFPC, medical and healthy system reform will focus on the linkage among health system reform, medical care system reform and drug distribution system reform, separation of clinic from pharmacy and tiered medical services during the 13th Five-Year Plan period.
Compared with 15 percent of GDP in US and over 10 percent of GDP in Canada and Japan, health industry only accounts for 4 percent - 5 percent of GDP in China. Analysts estimated that once "Health China"became state strategy, ten trillion yuan of investment would be made in the sector.
A-share investors are suggested to pay close attention to Searainbow Holding (000503.SZ), Andon Health Co., Ltd. (002432.SZ), Huapont Life Sciences Co. (002004.SZ) and Lejin Health Co. Ltd. (300247.SZ). (Edited by Bai Jiechun, baijc@xinhua.org)
A single purchase
